Why WORK Medical Technology Group LTD’s (WOK) Stock Is Down 86.09%
As of Wednesday, September 24, WORK Medical Technology Group LTD’s WOK share price has dipped by 86.09%, which has investors questioning if this is right time to buy.Omar Beirat
Stock Evaluator: WORK Medical Technology Group LTD (WOK)
WORK Medical Technology Group LTD WOK
$1.09
-0.25
-18.66%
October 16, 2026 4:00:00 PM
EST
Volume: 104,219
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People’s Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Commentary & Analysis
Financial Summary
| Share Statistics | WOK | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.6 | $382.9 | 2% |
|
| Shares Out (Mil) | na | 40.9 | na |
|
| Institutional Ownership | 99.3% | 83.6% | 87% |
|
| Float (Mil) | 2.3 | 35.5 | 6% |
|
| Beta | 1.75 | 0.86 | 88% |
|
| Avg Daily Volume (000s) | 55 | 301 | 30% |
|
| Price Change (52-week) |
(100.0%) | 61.8% | 0% |
|
| Growth | WOK | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (28.5%) | 11.8% | 1% |
|
| Net Income (5yr) | (23.9%) | (5.5%) | 17% |
|
| EPS (5yr) | na | 10.6% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | WOK | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $11 | $141 | 9% |
|
| Net Income (TTM) (Mil) | ($5) | ($9) | 34% |
|
| EPS (TTM) | na | ($0.400) | na |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | ($2) | 31% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $1 | 46% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $10 | $418 | 8% |
|
| Valuation | WOK | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.50 | na |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | WOK | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.0% | 58.7% | 17% |
|
| Net Margin | (42.0%) | (6.9%) | 13% |
|
| ROA | (10.8%) | (12.2%) | 25% |
|
| ROE | (20.9%) | (10.7%) | 23% |
|
| Liabilities to Assets | 32.8% | 47.2% | 24% |
|
| F-Score | 3 | 4 | na |
|
WORK Medical Technology Group LTD did not pass any screens on 10/16/2026.
